Precision Medicine
The cloud-based electronic health record vendor will be showing new features and functionalities that CEO Girish Navani says make the software smarter so it helps doctors.
A growth projection of 25.6 percent by 2022 is expected, says new Kalorama report, and so are changes in the doctor-patient relationship.
The iconic entertainer claims the biotech mogul lied to the LA Times about knowing she was a stakeholder in Altor Biosciences.
SPONSORED
|
10:51 am |
January 10, 2018
|
10:51 am |
January 10, 2018
Bryce Olson, global marketing director, health and life sciences at Intel Corp., discusses the data explosion.
Companies will employ advanced analytics to develop clinical decision support software for earlier diagnoses and targeted treatment.
The company wants to help employer groups offer genetic testing to employees through confidential consults with providers and includes a telemedicine option.
The Cancer Center will deploy data and analytics tools for clinical research and personalized treatment at the new Miami Cancer Institute.
The tech giants both participated in a VC round and three days later, each had also invested in another emerging company with cutting-edge technology tailored for healthcare.
The aim is to create a universal blood test that detects autoimmune disorders, cancer, diseases and infections, the companies said.
The National Institutes of Health’s Genomic Working Group said researchers should build the program in a systemic way before reaching the planned 1 million participants.